ContractFirst License Agreement • September 29th, 2023 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances)
[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
FIRST LICENSE AGREEMENT AMENDMENTFirst License Agreement • February 22nd, 2011 • SensiVida Medical Technologies, Inc. • Surgical & medical instruments & apparatus
THE FIRST LICENSE AGREEMENT AMENDMENT is made as of April 20, 2010 by ROCHESTER BIOVENTURE CENTER, INC., ("Licensor"), and SENSIVIDA MEDICAL TECHNOLOGIES, INC. ("Licensee").
FIRST LICENSE AGREEMENT BETWEEN LEXEO THERAPEUTICS, LLC AND CORNELL UNIVERSITY FOR DOCKET NO. D-6083 DOCKET NO. D-9134 DOCKET NO. D-9179 DOCKET NO. D-9187 DOCKET NO. D-9232 DOCKET NO. D-9325 DOCKET NO. D-9471 DOCKET NO. D-9472 CTL CONTRACT NO. [***]First License Agreement • September 29th, 2023 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This First License Agreement (this “Agreement”) is made by and between LEXEO Therapeutics, LLC, a Delaware limited liability company, having an office at 430 East 29th Street, 14th Floor, New York, NY 10016 (“LICENSEE”), and Cornell University, a New York education corporation (“Cornell”), as represented by its Cornell Center for Technology Licensing (“CTL”) at 395 Pine Tree Road, Suite 310, Ithaca, NY 14850. Cornell and LICENSEE each may be referred to herein as a “Party” and together as the “Parties.”
ContractFirst License Agreement • May 5th, 2022 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
[ *** ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
ContractFirst License Agreement • August 16th, 2023 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances)
[ *** ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
Exhibit 10.6 AMENDMENT TO FIRST LICENSE AGREEMENT This Amendment, dated as of this 3rd day of March, 2005 (this "AMENDMENT") to the License Agreement dated March 19, 2001 (the "FIRST LICENSE AGREEMENT"), is made by and between Cytomedix, Inc....First License Agreement • March 31st, 2005 • Cytomedix Inc • Services-commercial physical & biological research
